Stem Cell Manufacturing Market by 2026 - Global Trends, Share Analysis, Leading Players, Business Opportunities
- In January 2021, Thermo Fisher Scientific acquired Henogen S.A., Novasep's viral vector manufacturing business, to strengthen its capabilities for cell and gene vaccines and therapies globally.
View full press release